CS274628B2 - Method of oxophthalazinylacetic acids production with benzothiathole side chain - Google Patents

Method of oxophthalazinylacetic acids production with benzothiathole side chain

Info

Publication number
CS274628B2
CS274628B2 CS392488A CS392488A CS274628B2 CS 274628 B2 CS274628 B2 CS 274628B2 CS 392488 A CS392488 A CS 392488A CS 392488 A CS392488 A CS 392488A CS 274628 B2 CS274628 B2 CS 274628B2
Authority
CS
Czechoslovakia
Prior art keywords
oxophthalazinylacetic
benzothiathole
side chain
acids production
oxophthalizinyl
Prior art date
Application number
CS392488A
Other languages
Czech (cs)
English (en)
Other versions
CS392488A2 (en
Inventor
Banavara Lakshmana Mylari
William James Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS392488A2 publication Critical patent/CS392488A2/cs
Publication of CS274628B2 publication Critical patent/CS274628B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CS392488A 1987-06-09 1988-06-07 Method of oxophthalazinylacetic acids production with benzothiathole side chain CS274628B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5989987A 1987-06-09 1987-06-09

Publications (2)

Publication Number Publication Date
CS392488A2 CS392488A2 (en) 1990-08-14
CS274628B2 true CS274628B2 (en) 1991-09-15

Family

ID=22026001

Family Applications (1)

Application Number Title Priority Date Filing Date
CS392488A CS274628B2 (en) 1987-06-09 1988-06-07 Method of oxophthalazinylacetic acids production with benzothiathole side chain

Country Status (26)

Country Link
EP (1) EP0295051B1 (de)
JP (1) JPH0676391B2 (de)
KR (1) KR900004698B1 (de)
CN (1) CN1024347C (de)
AT (1) ATE90347T1 (de)
AU (1) AU593742B2 (de)
CA (1) CA1321791C (de)
CS (1) CS274628B2 (de)
DD (3) DD280323A5 (de)
DE (1) DE3881583T2 (de)
DK (1) DK309988A (de)
EG (1) EG18613A (de)
ES (1) ES2040853T3 (de)
FI (1) FI93835C (de)
HU (1) HU205108B (de)
IE (1) IE61499B1 (de)
IL (1) IL86660A0 (de)
MY (1) MY103573A (de)
NO (1) NO176317C (de)
NZ (1) NZ224937A (de)
PH (1) PH25928A (de)
PL (1) PL157690B1 (de)
PT (1) PT87669B (de)
SU (1) SU1678208A3 (de)
YU (1) YU46696B (de)
ZA (1) ZA884075B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322153A3 (de) * 1987-12-21 1990-08-16 Pfizer Inc. Heterozyklyl Oxophtalazynyl-Essigsäuren
WO1989006651A1 (en) * 1988-01-19 1989-07-27 Pfizer Inc. 1h-indazole-3-acetic acids as aldose reductase inhibitors
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
WO1991009019A1 (en) * 1989-12-15 1991-06-27 Pfizer Inc. Substituted oxophthalazinyl acetic acids and analogs thereof
US5064830A (en) * 1990-08-02 1991-11-12 Pfizer Inc. Lowering of blood uric acid levels
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
BR9205810A (pt) * 1991-03-28 1994-06-28 Pfizer Acidos piridazinona acéticos
FR2682108B1 (fr) * 1991-10-07 1994-01-07 Lipha Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
DE69405193T2 (de) * 1993-10-06 1998-01-02 Sumika Fine Chemicals Co Ltd Verfahren zur Herstellung von Alkyl-3-phthalidylidenacetat
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (de) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph von Zopolrestat Monohydrat
SG82702A1 (en) * 1999-09-28 2001-08-21 Ebauchesfabrik Eta Ag Timepiece including a movement mounted in a casing ring
CN116970317A (zh) * 2023-03-20 2023-10-31 安徽庆丰涂料科技有限公司 可呼吸的负离子抗菌涂料及其加工工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
JPS5931509B2 (ja) * 1979-06-06 1984-08-02 昭和電工株式会社 ３−ヒドロキシ−３−メチルフタリド又はその核置換体の製造法
DE3684410D1 (de) * 1985-11-07 1992-04-23 Pfizer Heterocyclische oxophthalazinylessigsaeure.

Also Published As

Publication number Publication date
FI882722A0 (fi) 1988-06-08
ES2040853T3 (es) 1993-11-01
NO882516L (no) 1988-12-12
PH25928A (en) 1991-12-19
FI93835B (fi) 1995-02-28
CN1024347C (zh) 1994-04-27
YU46696B (sh) 1994-04-05
DE3881583D1 (de) 1993-07-15
SU1678208A3 (ru) 1991-09-15
AU593742B2 (en) 1990-02-15
PT87669A (pt) 1988-07-01
EP0295051A2 (de) 1988-12-14
PT87669B (pt) 1992-09-30
CN88103507A (zh) 1988-12-28
PL272899A1 (en) 1989-07-10
HU205108B (en) 1992-03-30
CA1321791C (en) 1993-08-31
YU111188A (en) 1989-12-31
NZ224937A (en) 1991-01-29
IE881716L (en) 1988-12-09
EP0295051B1 (de) 1993-06-09
KR890000476A (ko) 1989-03-14
NO882516D0 (no) 1988-06-08
IL86660A0 (en) 1988-11-30
JPH0676391B2 (ja) 1994-09-28
EP0295051A3 (en) 1989-03-22
JPS643173A (en) 1989-01-06
DK309988D0 (da) 1988-06-08
NO176317C (no) 1995-03-15
AU1749188A (en) 1988-12-15
FI882722A (fi) 1988-12-10
FI93835C (fi) 1995-06-12
DD281600A5 (de) 1990-08-15
EG18613A (en) 1993-08-30
ATE90347T1 (de) 1993-06-15
MY103573A (en) 1993-08-28
CS392488A2 (en) 1990-08-14
ZA884075B (en) 1990-02-28
PL157690B1 (en) 1992-06-30
KR900004698B1 (ko) 1990-07-02
NO176317B (no) 1994-12-05
DD280323A5 (de) 1990-07-04
DE3881583T2 (de) 1993-09-16
DD280320A5 (de) 1990-07-04
IE61499B1 (en) 1994-11-02
DK309988A (da) 1988-12-10

Similar Documents

Publication Publication Date Title
CS274628B2 (en) Method of oxophthalazinylacetic acids production with benzothiathole side chain
AU2140788A (en) Process for the asymmetric production of carboxylic acid esters and/or carboxylic acids
DE3765157D1 (de) Verfahren zur herstellung von macrolid-derivaten.
EP0246603A3 (en) 4-halogeno-2-oxyimino-3-oxobutyric acids
IL80425A0 (en) Process for the enzymatic separation of the opticalisomers of 2-aminobutanol
AU605754B2 (en) Process for acylating amines with 2-benzothiazolyl thioesters of carboxylic acids
ZA885968B (en) A process for the enzymatic preparation of optically active phosphorus-containing functional acetic acid derivatives
EP0295548A3 (en) Method for the production of pentenoic acid esters from esters of formyl-valeric acid
EP0286981A3 (en) Method for the production of carboxylic acid methyl esters
ZA891486B (en) Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
IE883467L (en) Preparing acid anhydrides from acids
IL102576A0 (en) Process for the production of phthalazineacetic acid ester derivatives

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MK4A Patent expired

Effective date: 20050607